GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Beginning Cash Position

Autolus Therapeutics (Autolus Therapeutics) Beginning Cash Position : $240.34 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Beginning Cash Position?

Autolus Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2024 was $240.34 Mil.

Autolus Therapeutics's quarterly Beginning Cash Position declined from Sep. 2023 ($307.83 Mil) to Dec. 2023 ($256.85 Mil) and declined from Dec. 2023 ($256.85 Mil) to Mar. 2024 ($240.34 Mil).

Autolus Therapeutics's annual Beginning Cash Position increased from Dec. 2021 ($154.09 Mil) to Dec. 2022 ($310.68 Mil) and increased from Dec. 2022 ($310.68 Mil) to Dec. 2023 ($382.76 Mil).


Autolus Therapeutics Beginning Cash Position Historical Data

The historical data trend for Autolus Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Beginning Cash Position Chart

Autolus Therapeutics Annual Data
Trend Sep16 Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial 217.56 211.43 154.09 310.68 382.76

Autolus Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 382.76 343.36 307.83 256.85 240.34

Autolus Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Autolus Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Autolus Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Autolus Therapeutics (Autolus Therapeutics) Business Description

Traded in Other Exchanges
Address
191 Wood Lane, The MediaWorks, London, GBR, W12 7FP
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Autolus Therapeutics (Autolus Therapeutics) Headlines